Ghent University Academic Bibliography

Advanced

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 - A randomized controlled trial.

Simon Van Belle UGent, MR LICHINITSER, RM NAVARI, AM GARIN, M DECRAMER, A RIVIERE, M THANT, E BRESTAN, B BUI and K ELRIDGE, et al. (2002) CANCER. 94(11). p.3032-3041
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
CANCER
Cancer
volume
94
issue
11
pages
3032-3041 pages
Web of Science type
Article
Web of Science id
000175789900029
JCR category
ONCOLOGY
JCR impact factor
3.941 (2002)
JCR rank
21/112 (2002)
JCR quartile
1 (2002)
ISSN
0008-543X
language
English
UGent publication?
yes
classification
A1
id
165066
handle
http://hdl.handle.net/1854/LU-165066
date created
2004-01-14 13:40:00
date last changed
2008-02-22 22:47:51
@article{165066,
  author       = {Van Belle, Simon and LICHINITSER, MR and NAVARI, RM and GARIN, AM and DECRAMER, M and RIVIERE, A and THANT, M and BRESTAN, E and BUI, B and ELRIDGE, K and DE SMET, M and MICHELS, N and REINHARDT, RR and CARIDES, AD and EVANS, JK and GERTZ, BJ},
  issn         = {0008-543X},
  journal      = {CANCER},
  language     = {eng},
  number       = {11},
  pages        = {3032--3041},
  title        = {Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 - A randomized controlled trial.},
  volume       = {94},
  year         = {2002},
}

Chicago
Van Belle, Simon, MR LICHINITSER, RM NAVARI, AM GARIN, M DECRAMER, A RIVIERE, M THANT, et al. 2002. “Prevention of Cisplatin-induced Acute and Delayed Emesis by the Selective Neurokinin-1 Antagonists, L-758,298 and MK-869 - A Randomized Controlled Trial.” Cancer 94 (11): 3032–3041.
APA
Van Belle, S., LICHINITSER, M., NAVARI, R., GARIN, A., DECRAMER, M., RIVIERE, A., THANT, M., et al. (2002). Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 - A randomized controlled trial. CANCER, 94(11), 3032–3041.
Vancouver
1.
Van Belle S, LICHINITSER M, NAVARI R, GARIN A, DECRAMER M, RIVIERE A, et al. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 - A randomized controlled trial. CANCER. 2002;94(11):3032–41.
MLA
Van Belle, Simon, MR LICHINITSER, RM NAVARI, et al. “Prevention of Cisplatin-induced Acute and Delayed Emesis by the Selective Neurokinin-1 Antagonists, L-758,298 and MK-869 - A Randomized Controlled Trial.” CANCER 94.11 (2002): 3032–3041. Print.